Alzheimer's Disease: Addressing a Twenty-First Century Plague

Total Page:16

File Type:pdf, Size:1020Kb

Alzheimer's Disease: Addressing a Twenty-First Century Plague Rend. Fis. Acc. Lincei (2015) 26:251–262 DOI 10.1007/s12210-015-0453-y Alzheimer’s disease: addressing a twenty-first century plague Christopher M. Dobson1 Received: 11 July 2015 / Accepted: 13 July 2015 / Published online: 19 August 2015 Ó The Author(s) 2015. This article is published with open access at Springerlink.com Abstract Alzheimer’s disease represents one of the plagues of Egypt, recorded in the Book of Exodus, are greatest challenges to the social fabric and health care thought to have occurred between ca. 1500 and 1200 BCE, systems of the world since the great plagues of the Middle although there has been much speculation about the origins Ages. At the present time, there are some 40 million suf- of these events, including whether or not they are mythical, ferers from this disease worldwide, but it is predicted that or if they could have represented the consequences of a this number will rise to nearly 150 million by 2050. The period of climate change. In more recent history, devas- predominant reason for this rapidly increasing prevalence tating ‘plagues’ are better documented, such as the ‘Plague is the increase in longevity that has resulted from the of Athens’ in 430–426 BCE, which followed severe over- tremendous advances in public health and hygiene and in crowding in the city, accompanied by insanitary condi- medical and surgical interventions over the last century. tions, as people took refuge from the approaching Spartan This article discusses recent progress in our understanding army during the Peloponnesian War. It is thought that a of the molecular origins of Alzheimer’s disease and third of the population of Athens could have died from emerging ideas for new and rational therapeutic strategies disease at this time, speculated to be anything from typhoid by which to combat its onset and progression. to measles. Another well-documented plague from antiquity was the Keywords Protein misfolding Á Amyloid formation Á ‘Plague of Justinian’, which occurred in 541–544 AD in Neurodegenerative diseases Á Protein homeostasis Á Constantinople and throughout the Byzantine Empire. Aggregation mechanisms There is increasing evidence that this pandemic was the first recorded outbreak of bubonic plague, the disease that more than any other is often simply described as ‘the 1 Introduction plague’. Frequent outbreaks occurred in mediaeval Europe, the infection having spread from Asia along the increas- Plagues, or the rapid emergence of outbreaks of fatal dis- ingly heavily used trade routes. The most famous of these eases, have been a prominent feature of the human con- episodes was the ‘Great Mortality’ or the ‘Black Death’ dition throughout history (Dobson 2015). The ‘biblical’ that afflicted Europe in 1347–1353 AD, and is estimated to have killed one third of the population of the continent and to have caused unprecedented social and economic The 2014 International Feltrinelli Prize for Medicine was awarded by upheaval. There were other periodic outbreaks of bubonic the Accademia Nazionale dei Lincei to Prof. Christopher M. Dobson. This paper is an account of the lecture that the awardee delivered plague, including the ‘Great Plague’ of London in 1665, during the presentation ceremony on the 14 of November 2014. although none was as devastating as that of the mid-four- teenth century. Other diseases, however, ravaged the world, & Christopher M. Dobson including measles and smallpox, which spread like wildfire [email protected] amongst the populations of ‘new worlds’ such as the 1 Department of Chemistry, University of Cambridge, Americas and Australasia with the arrival of European Lensfield Road, Cambridge CB2 1EW, UK colonists, as the indigenous people had no immunity to 123 252 Rend. Fis. Acc. Lincei (2015) 26:251–262 these diseases that were previously unknown in those conditions, notably cancer and cardiovascular disease, regions (Dobson 2015; Haines and Steckel 2014). which are now the greatest causes of death in much of the With the massive overcrowding that occurred in cities as world outside sub-Saharan Africa. In the last few decades, a result of the increasing industrialisation in the nineteenth however, there has been a dramatic increase in another century, outbreaks of infectious diseases such as cholera group of disorders, collectively called dementias, of which and typhoid became common until the importance of the most common is Alzheimer’s disease (AD) (Knowles public health and hygiene became recognised. Then, in the et al. 2014). Dementia has recently been called a ‘twenty- aftermath of the First World War, perhaps the most lethal first century plague’, and indeed its rapidly increasing pandemic of all time occurred, the ‘Spanish flu’ of incidence and currently incurable nature is giving rise to 1918–1919, which is thought to have caused the deaths of the type of fears that in the past were associated with the 50 million people (more than the toll that resulted from the plagues of infectious diseases of the type discussed above. War itself). There is now increasing evidence that this ‘plague’ was the result of a strain of influenza similar to that of ‘bird flu’, outbreaks of which have generated much 3 The increasing number of cases of Alzheimer’s concern in recent years (Dobson 2015). disease Alzheimer first described the disease that bears his name in 2 Changes in human behaviour and the spread a lecture in 1906, after studying the case of a 51-year old of disease woman, Auguste Deter who was admitted to the Frankfurt Asylum suffering from severe dementia. At the time, her The modern investigation of such pandemics reveals close case was a curiosity, and indeed it is evident that she was links with rapid changes in human activities and lifestyles. suffering from a rare early onset form of AD. Indeed it was All of the classic plagues are of infectious diseases, both only some 40 years ago that AD began to be recognised as bacterial and viral, whose spread was dramatically an increasingly common condition among the elderly, but enhanced by increasing population densities, a process since then the number of cases has increased dramatically beginning with the change from a hunter-gatherer lifestyle within our ageing populations (Alzheimer’s Association more than 10,000 years ago, and by the increasing number 2015). The number of cases in the USA, for example, now of people travelling ever more rapidly over larger distances exceeds 5 million, and it is estimated that there are some 40 carrying the infectious agents; both of these factors million sufferers worldwide. This number is anticipated to increase the risk of transmission, particularly to popula- rise to about 135 million by 2050, of whom more than 70 % tions that have not previously been exposed to such dis- will be in low or middle income nations; AD is, therefore, eases. The changes in human behaviour that resulted in no longer a phenomenon confined to the wealthy nations of outbreaks of disease were, however, accompanied by an the world (Fig. 1). This increase in the number of cases is increasing realisation of their causes and of effective means entirely attributable to the increasing number of people over of prevention and treatment. Improvements in sanitation the age of 65, where the incidence of symptoms is between and hygiene, and the development of vaccines and of 1 and 2 % of the population, rising to between one-third and antibiotics, have been dramatic, such that in much of the one-half of those living to the age of 85. world the chances of dying from the classic infectious The financial burdens of this condition are enormous diseases that plagued humanity until modern times have because of the need for continuous care of patients, often been hugely reduced. The risk of pandemics has not been for years. In the USA, for example, the costs of AD are completely abolished, however, as resistant strains of many estimated to approach $200 billion this year and are pre- diseases that were thought to be have been largely sup- dicted to exceed $1 trillion by 2050 (Fig. 2); indeed in the pressed, such as tuberculosis, have emerged, and ‘new’ next 35 years, the cost of care and associated issues for AD types of disease have appeared, such as HIV/AIDS and sufferers in the USA alone is anticipated to be approxi- Ebola (Dobson 2015; Peacock 2014). Even in such cases, mately $20 trillion. Moreover, the extremely debilitating however, modern science has so far managed to limit and uniquely distressing nature of dementia has huge significantly the severity of these more recent ‘plagues’. implications for the stability of society and tremendous The decline in the number of cases of infectious disease challenges for the health care systems of the world. It is for has led to greatly increased lifespans in most parts of the this reason that dementia has recently become recognised modern world; life expectancy in the most highly devel- as an emerging international catastrophe, resulting in the oped countries is now about 80 years compared to first G8 Dementia Summit in London in 2013 where the approximately 50 years a century ago. The result, however, need to increase spending on research into the nature of the has been a large increase in cases of non-infectious disease, and into new approaches to the development of 123 Rend. Fis. Acc. Lincei (2015) 26:251–262 253 Fig. 1 Global life expectancy for both sexes in 2012. Source World Health Organization Map Production: Health Statistics and Information Systems (HIS), World Health Organization (2014) Fig. 2 Predicted costs of Alzheimer’s disease in the USA. 1070 Taken from ‘Changing the Trajectory of Alzheimer’s Disease: A National 906 Imperative’. Alzheimer’s Association, May 2010.
Recommended publications
  • Towards Complete Descriptions of the Free Energy Landscapes of Proteins
    Sequence-Based Predictions of Protein Solubility Michele Vendruscolo Department of Chemistry University of Cambridge Protein folding The fundamental code for protein folding is provided by the amino acid sequence. Amino acid sequences encode the whole free energy landscape of proteins Not only the native structure but also all the other states and the corresponding pathways of interconversion are encoded in the amino acid sequence of a protein. Does the amino acid sequence encode also for aggregation? Physico-chemical principles of protein aggregation Hydrophobicity, charge and secondary structure propensity are correlated with the changes in the aggregation rates upon mutation. Chiti et al. Nature 2003 Sequence-based prediction of aggregation rates The combination of sequence-dependent factors and environmental factors enables the prediction of aggregation rates over a broad range of timescales (from seconds to weeks) 0 ln(k) = åakIk + åak Ek -1 -2 ) k ( ln(k): logarithm of the aggregation rate k g o l -3 d e hydr t I : hydrophobicity a l -4 pat u c I : hydrophobic patterns l a C I : -helical propensity -5 I : -sheet propensity ch I : charge contribution -6 EpH: pH of the solution -7 -7 -6 -5 -4 -3 -2 -1 0 Eionic: ionic strength Experimental log(k ) Econc: polypeptide concentration DuBay et al. J. Mol. Biol. 2004 Prediction of aggregation-prone regions of -synuclein The aggregation propensity is a function of the physico-chemical properties of the amino acid sequence (hydrophobicity, charge, etc). We have developed the Zyggregator method to predict aggregation rates and aggregation-prone regions (www-vendruscolo.ch.cam.ac.uk) Tartaglia et al.
    [Show full text]
  • ALS) with Mutations in Angiogenin and Superoxide Dismutase 1
    Therapeutic strategies for the treatment of Amyotrophic Lateral Sclerosis (ALS) with mutations in Angiogenin and Superoxide Dismutase 1 by Krishna Chaitanya Aluri Bachelor of Pharmacy, Rajiv Gandhi University of Health Sciences Master of Science in Biopharmaceutical Science, Northeastern University A dissertation submitted to The Faculty of the College of Science of Northeastern University in partial fulfillment of the requirements for the degree of Doctor of Philosophy April, 16, 2020 Dissertation directed by Jeffrey N. Agar Professor of Chemistry and Chemical Biology 1 Dedication “When I walk, I walk with you. Where I go, you're with me always.” ― Alice Hoffman, The Story Sisters, 2009. I dedicate this work to my family and friends. A special thanks to my parents Aluri Gopal Rao and Mallela Visalakshi; brother Venkata Vishnuvardan Aluri and wife Prathyusha Gundlapally for their inspiration and words of encouragement. I also dedicate this work to my friends Husain Attarwala, Arnik Shah, Aatman Doshi, Kirtika Asrani, Smith Patel and Ranjitha Gaddipati for their support. 2 Acknowledgments I would like to express my deep and sincere gratitude to Prof. Jeffrey N. Agar for continuous support and guidance. I would like to thank my fellow labmates Dr. Joseph P. Salisbury, Dr. Daniel P. Donnelly, Md. Amin Hossain, Durgalakshmi Sivasankar, and Nicholas D. Schmitt for their contributions and thoughtful discussions. I thank my thesis committee Prof. Alexander Ivanov, Prof. Ke Zhang, Dr. Jared R. Auclair, Dr. Roman Manetsch, and Dr. Saeho Chong for their insightful comments, time, and encouragement. I would like to thank our collaborators Dr. Jochen H.M. Prehn, Dr. Roman Manetsch, Dr.
    [Show full text]
  • Cabimer 2011-15
    2 INDEX 5 Welcome/Introduction by the Director 7 Cabimer by the Manager 9 Description of Research Activities 10 Molecular Biology Department Genome Instability & Cáncer Epigenetics and Gene Expression Chromatin Integrity and Function Mitochondrial Plasticity and Replication Chromosome Segregation 20 Stem Cell Department Cellular Therapy of the Diabetes Mellitus and its Complication Pancreatic Islets Pathophysiology Cell and Stem Cell Pancreas and Liver Development and Disease Pancreatic Isled Development and Regeneration Unit Cell Differentiation Laboratory DNA Damage Response 32 Cell Signalling Department Cell Death Signalling Cell Cicle and Oncogenesis Membrabe Traffic and Cytoskeleton in Cell Dynamics Neuronal Plasticity and Neurodegenerative Diseases Advance Therapy in Neuroprotection and Immune Regulation 42 Cell Therapy and Regenerative Medicine Department Retinal Degeneration: from Genetics to Therapy Survival Mechanisms of the Pancreatic Islets Cell Therapy for Neuropathologies DNA Double Strand Breaks Repair and Human Disease 51 Scientific Core Services Biological Safety Unit Biological Resources Cell Culture Citometry and Sorter GMP Genomics Microscopy Histology Model Organism Washing and Sterilization 61 General Core Services 62 Communication and Diffusion Publications Doctoral Theses Seminar Speakers 79 Master Students 81 Scientific Advisory Board 83 Where we are 3 4 WELCOME Andres Aguilera [email protected] DIRECTOR It is my pleasure to present the scientific report of CABIMER (Centro EMBO Young Investigators (Felipe Cortés and Pablo Huertas), or the Andaluz de Biología Molecular y Medicina Regenerativa / Andalusian recognition of several researchers of highly valuable research prizes Centre of Molecular Biology and Regenerative Medicine) for the pe- and distinctions (Benoit Gauthier, Felipe Cortés-Ledesma, Andrés riod 2011 to 2015. CABIMER is a groundbreaking multidisciplinary Aguilera).
    [Show full text]
  • A Natural Product Inhibits the Initiation of Α-Synuclein Aggregation And
    Correction NEUROSCIENCE Correction for “A natural product inhibits the initiation of α-synuclein aggregation and suppresses its toxicity,” by Michele Perni, Céline Galvagnion, Alexander Maltsev, Georg Meisl, Martin B. D. Müller, Pavan K. Challa, Julius B. Kirkegaard, Patrick Flagmeier, Samuel I. A. Cohen, Roberta Cascella, Serene W. Chen, Ryan Limboker, Pietro Sormanni, Gabriella T. Heller, Francesco A. Aprile, Nunilo Cremades, Cristina Cecchi, Fabrizio Chiti, Ellen A. A. Nollen, Tuomas P. J. Knowles, Michele Vendruscolo, Adriaan Bax, Michael Zasloff, and Christopher M. Dobson, which appeared in issue 6, February 7, 2017, of Proc Natl Acad Sci USA (114:E1009– E1017; first published January 17, 2017; 10.1073/pnas.1610586114). The authors note that Ryan Limbocker’s name incorrectly appeared as Ryan Limboker. The corrected author line appears below. The online version has been corrected. Michele Perni, Céline Galvagnion, Alexander Maltsev, Georg Meisl, Martin B. D. Müller, Pavan K. Challa, Julius B. Kirkegaard, Patrick Flagmeier, Samuel I. A. Cohen, Roberta Cascella, Serene W. Chen, Ryan Limbocker, Pietro Sormanni, Gabriella T. Heller, Francesco A. Aprile, Nunilo Cremades, Cristina Cecchi, Fabrizio Chiti, Ellen A. A. Nollen, Tuomas P. J. Knowles, Michele Vendruscolo, Adriaan Bax, Michael Zasloff, and Christopher M. Dobson www.pnas.org/cgi/doi/10.1073/pnas.1701964114 CORRECTION www.pnas.org PNAS | March 21, 2017 | vol. 114 | no. 12 | E2543 Downloaded by guest on September 28, 2021 A natural product inhibits the initiation of α-synuclein PNAS PLUS aggregation and suppresses its toxicity Michele Pernia,b, Céline Galvagniona,1, Alexander Maltsevc, Georg Meisla, Martin B. D. Müllera,b, Pavan K. Challaa, Julius B.
    [Show full text]
  • By Yulong Sun a Thesis Submitted in Conform
    MOLECULAR MECHANISMS OF AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA: NEW INSIGHTS INTO THE FORMATION OF TDP-43 PROTEIN ASSEMBLIES by Yulong Sun A thesis submitted in conformity with the requirements for the degree of Doctor of Philosophy Department of Medical Biophysics University of Toronto © Copyright by Yulong Sun 2018 Molecular Mechanisms of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia: New Insights into the Formation of TDP-43 Protein Assemblies Yulong Sun Doctor of Philosophy Department of Medical Biophysics University of Toronto 2018 Abstract Advances in modern medicine in the past century have dramatically improved the average life expectancy in the western world. Unfortunately, the molecular mechanisms that maintain the integrity of proteins in the body appear to be unable to keep pace. This has led to a growing prevalence of late-onset diseases involving abnormal accumulation of proteins, especially in the last century. The increase in occurrence of neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), Alzheimer’s disease (AD), Parkinson’s disease (PD), and transmissible spongiform encephalopathies such as prion disease, has become a great burden to the healthcare system. All of these diseases are currently incurable and fatal, but they share the common hallmark of misfolding and aggregation of proteins within the effected neurons. The discovery and characterization of such proteins have often led to the identification of potential targets for treatment and drug design. In the case of ALS, progressive death of upper and lower motor neurons leads to full-body paralysis, and patient death from respiratory failure. The cause of ALS is currently unknown, but remarkably, regardless of the type of ALS (familial or sporadic), the RNA binding protein, TDP-43, is found in 97% of cases as neuronal inclusions, suggesting a mechanistic role in disease pathogenesis.
    [Show full text]
  • 2021 International Symposium on Biomedical Engineering and Computational Biology (BECB 2021) Conference Program
    2021 International Symposium on Biomedical Engineering and Computational Biology (BECB 2021) Conference Program (China Standard Time, GMT +08:00) August 13-15, 2021 Online www.becbinfo.com TABLE OF CONTENTS Join a Meeting & Test ............................................................................................................................ 2 Part I Conference Schedule .................................................................................................................... 3 Part II Plenary Speeches ........................................................................................................................ 5 Plenary Speech 1 Detection of Carotid Artery Stenosis by Passive and Active Medical Infrared Thermal Imaging .................................................................................................................................... 5 Plenary Speech 2 Interaction of Protein Aggregates with Biological Membranes: A Key Event in Neurodegenerative Diseases. From Basic Science to Clinical Trials .................................................... 6 Plenary Speech 3 Spontaneous Neurological Recovery following Traumatic Spinal Cord Injuries ..... 7 Plenary Speech 4 Zaitsev Neighborhood for Cellular Automata........................................................... 9 Part III Poster Presentations ................................................................................................................. 10 Part IV Oral Presentations ..................................................................................................................
    [Show full text]
  • First Line of Title Second Line of Title
    MECHANISTIC INSIGHTS INTO THE ROLE OF PROTEIN INTERACTIONS ON THE AGGREGATION BEHAVIOR OF ANTI-STREPTAVIDIN IMMUNOGLOBULIN GAMMA-1 by Gregory V. Barnett A dissertation submitted to the Faculty of the University of Delaware in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemical Engineering Fall 2015 c 2015 Gregory V. Barnett All Rights Reserved ProQuest Number: 10014766 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a complete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. ProQuest 10014766 Published by ProQuest LLC (2016). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States Code Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, MI 48106 - 1346 MECHANISTIC INSIGHTS INTO THE ROLE OF PROTEIN INTERACTIONS ON THE AGGREGATION BEHAVIOR OF ANTI-STREPTAVIDIN IMMUNOGLOBULIN GAMMA-1 by Gregory V. Barnett Approved: Abraham M. Lenhoff, Ph.D. Chair of the Department of Chemical Engineering Approved: Babatunde Ogunnaike, Ph.D Dean of the College of Engineering Approved: Ann L. Ardis, Ph.D. Interim Vice Provost for Graduate and Professional Education I certify that I have read this dissertation and that in my opinion it meets the academic and professional standard required by the University as a dissertation for the degree of Doctor of Philosophy.
    [Show full text]
  • ISOBC Newsletter, Vol 12 No 3 Dec 2017
    2017 ISOBC NEWSLETTER Volume 12, Number 3 Dec 2017 Volume 12, Number3 Iran Society of Biophysical Chemistry 2017 ISOBC NEWSLETTER Volume 12, Number 3 A brief introduction to MRC Laboratory of Molecular Biology (LMB), Cambridge University Medical Research Council (MRC)-Laboratory of Molecular Biology (LMB) was established in 1913. It is a publicly funded government agency responsible for funding medical research in the United Kingdom. MRC Laboratory of Molecular Biology (LMB) is a world-class research laboratory in Cambridge dedicated to understanding important biological processes at the molecular level – with the goal of using this knowledge to tackle major problems in human health and disease. Over the years, the work of LMB scientists has resulted into winning 11 Nobel prizes (8 in the field of chemistry and 3 for physiology or medicine) as follows: 2017 – Richard Henderson “for developing cryo-electron microscopy for the high-resolution structure determination of biomolecules in solution” 2013 – Michael Levitt “for the development of multiscale models for complex chemical systems” 2009 – Venki Ramakrishnan “for studies of the structure and function of the ribosome” 2002 – Sydney Brenner, Bob Horvitz & John Sulston “for their discoveries concerning the ‘genetic regulation of organ development and programmed cell death’ in C. elegans” 1997 – John Walker “for their elucidation of the enzymatic mechanism underlying the synthesis of adenosine triphosphate (ATP)” 1984 – César Milstein & Georges Köhler “for theories concerning the specificity
    [Show full text]
  • Mechanistic Insights Into Proteins Association Through Molecular Dynamics
    This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Mechanistic insights into proteins association through molecular dynamics Chua, Khi Pin 2017 Chua, K. P. (2017). Mechanistic insights into proteins association through molecular dynamics. Doctoral thesis, Nanyang Technological University, Singapore. http://hdl.handle.net/10356/73025 https://doi.org/10.32657/10356/73025 Downloaded on 08 Oct 2021 05:59:21 SGT Mechanistic Insights Into Proteins Association Through Molecular Dynamics Khi Pin Chua Interdisciplinary Graduate School NTU Institute for Health Technologies 2017 Mechanistic Insights Into Proteins Association Through Molecular Dynamics Khi Pin Chua Interdisciplinary Graduate School NTU Institute for Health Technologies A thesis submitted to the Nanyang Technological University in partial fulfilment of the requirement for the degree of Doctor of Philosophy 2017 i Acknowledgments I would like to express the utmost gratitude to my supervisor, Associate Professor Chew Lock Yue for his guidance throughout the four years of my doctoral study. He has been the biggest source of motivation for me. His insistence in doing science the right way is an inspiration to all of us in the lab. Additionally, I would like to thank my co-supervisor, Associate Professor Mu Yuguang for steering me in the right direction when I was lost. His experience in the molecular dynamics field has been one of the main factors I learnt so much during the past four years. Other than that, I would like to thank my mentor, Associate Professor Konstantin Pervushin for giving me valuable feedbacks in the projects I have done during our meetings.
    [Show full text]
  • 2010: Science Matters!!!
    2010: Science matters!!! http://www.nauka2010.com/elpart/nauka2010/science/signed.php Signatories 1. Pavel Wiegmann, University of Chicago; 2. Professor Paolo Furlan, Department of Physics of the University of Trieste; 3. Giuseppe Mussardo, Professor of Theoretical Physics, SISSA, Trieste (Italy); 4. Clisthenis P. Constantinidis, Física, Universidade Federal do Espírito Santo, Vitória, Brasil; 5. Zlatan Tsvetanov, Research Prof., Johns Hopkins University, Baltimore, MD 21218, USA; 6. Jean-Bernard ZUBER, Pr, Universite Pierre et Marie Curie, Paris, France; 7. Luiz Agostinho Ferreira (Full Professor), Instituto de Fisica de Sao Carlos, IFSC/USP, Brazil; 8. Sylvain Ribault, Universite Montpellier 2, France; 9. Baseilhac Pascal, PhD, LMPT Tours - CNRS; 10. Francesco Sardelli, University of Tours (FRANCE); 11. Professor Nathan Berkovits, IFT-UNESP, Sao Paulo; 12. Richard Kerner, Professor of Physics, University Pierre et Marie Curie, Paris, France; 13. Cosmas Zachos, Argonne National Laboratory; 14. almut beige, dr, university of leeds, uk; 15. S.L. Woronowicz, Professor, University of Warsaw; 16. Angel Ballesteros, Dr., Universidad de Burgos, Spain; 17. Loic Villain, PhD, LMPT (Univ. Tours, France); 18. Roberto Longo, Center for Mathematics and Theoretical Physics, Rome; 19. Stefan Theisen, Professor, Max-Planck-Institut Albert-Einstein-Institut; 20. Alex Kehagias, National Technical University of Athens; 21. Patrick Moylan, Associate Professor of Physics, The Pennsylvania State University; 22. Van Proeyen, Antoine, professor, K.U. Leuven, Belgium; 23. Prof. Dr. Alejandro Frank, Director, Instituto de Ciencias Nucleares, UNAM; 24. Victor Kac, Professor of Mathematics, Massachusetts Institute of Technology; 1 of 297 6/8/2018, 6:20 PM 2010: Science matters!!! http://www.nauka2010.com/elpart/nauka2010/science/signed.php 25.
    [Show full text]
  • Document 5.1
    AE AGM, 27 June 2016 Document 5.1 CONSOLIDATED ANNUAL ACTIVITIES REPORT FOR 2015 ‘The Academy of Europe’ Registered office Room 251, Senate House, Malet Street, London WC1E 7HU Tele: +44 (0) 20 7862 5784 Email: [email protected] Web: http://www.ae-info.org Company limited by Guarantee and registered at Companies House. Registration number 07028223 Registered with the Charity Commission, registration number 1133902 1 THE TRUSTEES, AND COUNCIL OF THE ACADEMIA EUROPAEA Board of TRUSTEES (at 31 December 2015) Officers President: Professor Sierd Cloetingh Utrecht, (elected June 2014, renewable at AGM of 2017) Vice President: Professor Anne Buttimer Dublin, (till 2018) Hon. Treasurer: Professor Sir Roger Elliott Oxford, (till September 2015) Professor Peter Scott London (from September 2015) Co-opted Members: Professor Theo D’haen Leuven, (till 2016) Professor Ole Petersen Cardiff, (till 2017) Professor Hermann Maurer Graz, (till end 2015) Appointed by Council: Professor Balazs Gulyas Stockholm, (till Dec. 2016) Professor Don Dingwell Munich, (till 2017) Professor Svend Erik Larsen Copenhagen, (till 2017) At the time of writing this report, the number of independent members elected to Council was set at a maximum of three. The Chairs of the Academic Sections are de facto members of the Council. Periods of office of Section chairs are as described in the regulations. The list of Section chairs, as at 31 December 2015, is at annex 1a of this report. Three members of the Council are nominated to the Board of Trustees – Professors Gulyas, Dingwell and Larsen. Prof. D’Haen is the Editor-in-Chief of the European Review. Prof.
    [Show full text]
  • Tentative Program and Timetable
    5. Ulm Meeting – Biophysics of Amyloid Formation Virtual meeting 16 February 2021 09:00 Margaret Sunde | University of Sydney, Australia RHIM functional amyloids operating for and against microbial infection 09:30 Meytal Landau | Technion - Israel Institute of Technology, Israel Functional supramolecular structures in infectious diseases as targets and therapeutics 10:00 Simon Alberti | Technical University of Dresden, Germany Biomolecular condensates at the nexus of stress, aging and protein aggregation disease 10:30 Raffaele Mezzenga | ETH Zurich, Switzerland Amyloid liquid crystalline phase separation ___________________________________________________________________________________________________________ 11:00 Break ____________________________________________________________________________________________________________ 11:30 Yuji Goto | University of Osaka, Japan Breakdown of supersaturation barrier links protein folding to amyloid formation 12:00 Sheena E. Radford | University of Leeds, UK Early steps in amyloid assembly: The achilles heel of a disease mechanism 12:30 Tuomas Knowles | University of Cambridge, UK Kinetics of protein aggregation ____________________________________________________________________________________________________________ 13:00 Break ____________________________________________________________________________________________________________ 14:00 Adriano Aguzzi | University Hospital Zurich, Switzerland Modifiers of prion propagation and toxicity 14:30 Mathias Jucker | University of Tübingen, Germany
    [Show full text]